Find a Tender
complete
Official procurement procedure
NHS National Pharmaceuticals - Everolimus and terminated agreement products
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS National Pharmaceuticals - Everolimus and terminated agreement products". Published status: complete. Published value: Value not published. 3 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The NHS Commissioning Board (operating under the name of NHS England) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
46Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England) | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published28 Sept 2021, 12:36 BST | Last source update28 Sept 2021, 12:36 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-02a471 | ||
What is being bought
Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022
What changed
From the official release history
- tender value changed
28 Sept 2021, 12:36 BST - Status changed to complete
28 Sept 2021, 12:36 BST - Official notice release published
28 Sept 2021, 12:36 BST - Submission deadline changed to published date
28 Sept 2021, 12:36 BST - Published value updated to £18,720,512
9 Apr 2021, 15:35 BST - Status changed to active
9 Apr 2021, 15:35 BST - Official notice release published
9 Apr 2021, 15:35 BST - Submission deadline changed to 26 Apr 2021, 13:00 BST
9 Apr 2021, 15:35 BST - Buyer information updated
9 Apr 2021, 15:35 BST
Lots and requirements (3)
Published by the contracting authority
- Lot 1 · #1Lot 1 - CM/PHG/21/5632/00 EverolimuscancelledPublished valueNot publishedInvitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632/00Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Lot 2 - CM/PHG/21/5632/01 Oral (plus non parenteral) productscancelledPublished valueNot publishedInvitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Lot 3 - CM/PHG/21/5632/02 Hospital Only productscancelledPublished valueNot publishedInvitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
28 Sept 2021, 12:36 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1 - Contract active
Signed 8 Jun 2021, 00:00 BST · £1
Commercial outcome and competition
Awards Selective Supplies Ltd. Not published · Not published · active Dr.Reddy's Laboratories (UK) Limited Not published · Not published · active Bristol Laboratories Limited Not published · Not published · active Drugsrus Ltd Not published · Not published · active Bowmed Ibisqus Limited Not published · Not published · active Martindale Pharma Not published · Not published · active Milpharm Ltd/aurobinbdo Not published · Not published · active Teva UK Limited Not published · Not published · active Crescent Pharma Ltd Not published · Not published · active Fresenius Kabi Limited Not published · Not published · active Ranbaxy UK Not published · Not published · active Mylan Not published · Not published · active Accord-UK Ltd Not published · Not published · active Medreich PLC Not published · Not published · active Torrent Pharma UK Ltd Not published · Not published · active Selective Supplies Ltd. Not published · Not published · active Fresenius Kabi Limited Not published · Not published · active Ranbaxy UK Not published · Not published · active Mylan Not published · Not published · active Accord-UK Ltd Not published · Not published · active Medreich PLC Not published · Not published · active Torrent Pharma UK Ltd Not published · Not published · active Dr.Reddy's Laboratories (UK) Limited Not published · Not published · active Bristol Laboratories Limited Not published · Not published · active Drugsrus Ltd Not published · Not published · active Bowmed Ibisqus Limited Not published · Not published · active Martindale Pharma Not published · Not published · active Milpharm Ltd/aurobinbdo Not published · Not published · active Teva UK Limited Not published · Not published · active Crescent Pharma Ltd Not published · Not published · active Selective Supplies Ltd. Not published · Not published · active Dr.Reddy's Laboratories (UK) Limited Not published · Not published · active Bristol Laboratories Limited Not published · Not published · active Drugsrus Ltd Not published · Not published · active Bowmed Ibisqus Limited Not published · Not published · active Martindale Pharma Not published · Not published · active Milpharm Ltd/aurobinbdo Not published · Not published · active Teva UK Limited Not published · Not published · active Crescent Pharma Ltd Not published · Not published · active Fresenius Kabi Limited Not published · Not published · active Ranbaxy UK Not published · Not published · active Mylan Not published · Not published · active Accord-UK Ltd Not published · Not published · active Medreich PLC Not published · Not published · active Torrent Pharma UK Ltd Not published · Not published · active |
Contracts NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active NHS National Pharmaceuticals - Everolimus and terminated agreement products £1 · signed 8 Jun 2021, 00:00 BST · active |
Bid statistics bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) bids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) electronicBids: 3 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) bids: 24 (lot 2) bids: 24 (lot 2) bids: 24 (lot 2) bids: 24 (lot 2) bids: 24 (lot 2) |
Buyer and organisations in this procedure
The NHS Commissioning Board (operating under the name of NHS England)
Contracting authority GB-FTS-2505Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published